Skip to content

Observation of the Analgesic Effect of Celecoxib Combined with STA Painless Anesthesia Device in the Perioperative Period of Guided Bone Regeneration Surgery

Observation of the Analgesic Effect of Celecoxib Combined with STA Painless Anesthesia Device in the Perioperative Period of Guided Bone Regeneration Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122873
Enrollment
Unknown
Registered
2026-04-20
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar bone defect

Interventions

Control group:Pressure syringe injection of articaine injection solution
STA group:Injection of Articaine Injection using STA Painless Local Anesthesia Device
Celecoxib group:Oral administration of 0.4g celecoxib capsules before surgery, followed by injection of articaine injection using a pressure injector.
Experimental group:Oral administration of 0.4g celecoxib capsules before surgery, followed by injection of articaine injection using the STA painless local anesthesia device.

Sponsors

Hangzhou Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients classified as Class I or II according to the American Society of Anesthesiologists (ASA) classification; 2. Patients whose preoperative assessment indicates insufficient horizontal bone volume for direct implant placement, with approximately 3–4 mm of remaining horizontal bone volume, and who require guided horizontal bone regeneration; 3. Patients aged between 18 and 60 years; 4. Patients whose adjacent teeth in the surgical area are free of conditions such as pulpitis or apical periodontitis; 5. Patients who have not taken any analgesic medications within one week prior to surgery;

Exclusion criteria

Exclusion criteria: 1 .Individuals with severe and uncontrolled underlying diseases; 2 .those with a history of radiotherapy or chemotherapy within the past 5 years before surgery; 3. individuals with a history of allergy to celecoxib and non-steroidal anti-inflammatory drugs; 4. pregnant or breastfeeding women; 5. individuals with severe liver and kidney diseases and impaired liver and kidney function; 6. those taking bisphosphonates or antitumor drugs; 7. those requiring long-term use of analgesics or psychotropic drugs; 8. patients with uncontrolled periodontal disease;

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale for Pain Assessment;

Secondary

MeasureTime frame
Improved Dental Anxiety Scale Scoring;Number of oral painkillers taken within 48 hours post-surgery;Time of first pain medication administration within 48 hours post-surgery;Mean arterial pressure;Average heart rate;

Countries

china

Contacts

Public ContactShi Hengrui

Hangzhou Traditional Chinese Medicine Hospital

13777828654@163.com+86 137 7782 8654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026